Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics

Pharmacogenomics J. 2003;3(1):11-3. doi: 10.1038/sj.tpj.6500158.

Authors

L A Rohde¹, T Roman, M H Hutz

Affiliation

¹ ADHD Outpatient Clinic, Child and Adolescent Psychiatric Division, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil. [email protected]

PMID: 12629578
DOI: 10.1038/sj.tpj.6500158

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Attention Deficit Disorder with Hyperactivity / drug therapy*
Attention Deficit Disorder with Hyperactivity / genetics*
DNA-Binding Proteins / genetics
Dopamine Plasma Membrane Transport Proteins
Humans
Membrane Glycoproteins*
Membrane Transport Proteins*
Methylphenidate / therapeutic use
Nerve Tissue Proteins*
Pharmacogenetics / methods*
Pharmacogenetics / trends*
Saccharomyces cerevisiae Proteins*

Substances

DAT1 protein, S cerevisiae
DNA-Binding Proteins
Dopamine Plasma Membrane Transport Proteins
Membrane Glycoproteins
Membrane Transport Proteins
Nerve Tissue Proteins
Saccharomyces cerevisiae Proteins
Methylphenidate